DOP2002000449A - Sal sodica de un inhibidor de integradasa del vih. - Google Patents
Sal sodica de un inhibidor de integradasa del vih.Info
- Publication number
- DOP2002000449A DOP2002000449A DO2002000449A DO2002000449A DOP2002000449A DO P2002000449 A DOP2002000449 A DO P2002000449A DO 2002000449 A DO2002000449 A DO 2002000449A DO 2002000449 A DO2002000449 A DO 2002000449A DO P2002000449 A DOP2002000449 A DO P2002000449A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- sodium salt
- hiv
- inhibitor
- integradasa
- compound
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- NOJNFULGOQGBKB-UHFFFAOYSA-M sodium;3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoate Chemical compound [Na+].C1=NC(OCC)=CC=C1C(C=C1)=CC=C1CN1C2=CC=C(OCC=3N=CC(C)=CC=3)C=C2C(SC(C)(C)C)=C1CC(C)(C)C([O-])=O NOJNFULGOQGBKB-UHFFFAOYSA-M 0.000 title 1
- 229940126062 Compound A Drugs 0.000 abstract 4
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 4
- 208000030507 AIDS Diseases 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 229940099797 HIV integrase inhibitor Drugs 0.000 abstract 1
- 239000003084 hiv integrase inhibitor Substances 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 159000000000 sodium salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31337301P | 2001-08-17 | 2001-08-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2002000449A true DOP2002000449A (es) | 2003-05-15 |
Family
ID=23215462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2002000449A DOP2002000449A (es) | 2001-08-17 | 2002-08-15 | Sal sodica de un inhibidor de integradasa del vih. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6924282B2 (enExample) |
| EP (1) | EP1430058A1 (enExample) |
| JP (1) | JP2005501857A (enExample) |
| AR (1) | AR036256A1 (enExample) |
| CA (1) | CA2456206A1 (enExample) |
| DO (1) | DOP2002000449A (enExample) |
| WO (1) | WO2003016315A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ525088A (en) * | 2000-10-12 | 2004-11-26 | Merck & Co Inc | Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| AU2003220170B2 (en) * | 2002-03-15 | 2008-12-11 | Merck Sharp & Dohme Corp. | N-(Substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as HIV integrase inhibitors |
| CA2532064A1 (en) * | 2003-07-15 | 2005-02-03 | Merck & Co., Inc. | Hydroxypyridine cgrp receptor antagonists |
| US20070185007A1 (en) * | 2003-09-19 | 2007-08-09 | Haolun Jin | Aza-quinolinol phosphonate integrase inhibitor compounds |
| DE602005010413D1 (de) * | 2004-04-14 | 2008-11-27 | Zhenhong R Cai | Phosphonatanaloga von hiv-integrasehemmerverbindungen |
| NZ575831A (en) | 2006-09-29 | 2011-12-22 | Idenix Pharmaceuticals Inc | Enantiomerically pure phosphoindoles as hiv inhibitors |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2632639B1 (fr) | 1988-06-09 | 1990-10-05 | Sanofi Sa | Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent |
| IL101860A0 (en) | 1991-05-31 | 1992-12-30 | Ici Plc | Heterocyclic derivatives |
| US5681832A (en) | 1995-02-17 | 1997-10-28 | The United States Of America As Represented By The Department Of Health And Human Services | Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity |
| US5945431A (en) | 1996-03-15 | 1999-08-31 | Biochem Therapeutics Incorporated | Cytomegalovirus inhibiting compounds |
| US6310211B1 (en) * | 1996-09-10 | 2001-10-30 | Pharmacia & Upjohn Company | 8-hydroxy-7-substituted quinolines as anti-viral agents |
| ATE300521T1 (de) | 1996-09-25 | 2005-08-15 | Astrazeneca Ab | Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern |
| KR20010014262A (ko) | 1997-06-30 | 2001-02-26 | 닛뽄카야쿠가부시키가이샤 | 신규 나프티리딘 유도체 또는 그 염 |
| SI20270A (sl) | 1997-08-25 | 2000-12-31 | Neurogen Corporation | Substituirani 4-okso-naftiridin-3-karboksamidi kot ligandi možganskih GABA receptorjev |
| US6093732A (en) | 1997-12-22 | 2000-07-25 | Pharmacia & Upjohn Company | 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| US6262055B1 (en) | 1998-06-03 | 2001-07-17 | Merck & Co., Inc. | HIV integrase inhibitors |
| US6380249B1 (en) | 1998-06-03 | 2002-04-30 | Merck & Co., Inc. | HIV integrase inhibitors |
| US6306891B1 (en) | 1998-06-03 | 2001-10-23 | Merck & Co., Inc. | HIV integrase inhibitors |
| AU5880600A (en) | 1999-06-25 | 2001-01-31 | Merck & Co., Inc. | 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
| US6730682B2 (en) | 2000-07-12 | 2004-05-04 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
| GB0017676D0 (en) | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
| NZ525088A (en) * | 2000-10-12 | 2004-11-26 | Merck & Co Inc | Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| DE60218511T2 (de) | 2001-10-26 | 2007-10-25 | Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.P.A. | Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase |
| EP1441735B1 (en) | 2001-10-26 | 2006-02-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
-
2002
- 2002-08-09 AR ARP020103023A patent/AR036256A1/es unknown
- 2002-08-13 EP EP02794880A patent/EP1430058A1/en not_active Withdrawn
- 2002-08-13 CA CA002456206A patent/CA2456206A1/en not_active Abandoned
- 2002-08-13 JP JP2003521237A patent/JP2005501857A/ja not_active Withdrawn
- 2002-08-13 WO PCT/US2002/025675 patent/WO2003016315A1/en not_active Ceased
- 2002-08-14 US US10/218,537 patent/US6924282B2/en not_active Expired - Fee Related
- 2002-08-15 DO DO2002000449A patent/DOP2002000449A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1430058A1 (en) | 2004-06-23 |
| WO2003016315A1 (en) | 2003-02-27 |
| US20030119823A1 (en) | 2003-06-26 |
| JP2005501857A (ja) | 2005-01-20 |
| CA2456206A1 (en) | 2003-02-27 |
| US6924282B2 (en) | 2005-08-02 |
| AR036256A1 (es) | 2004-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN07215A1 (en) | Potassium salt of an hiv integrase inhibitor | |
| LV12719A (lv) | Benzoxazinones as inhibitors of hiv reverse transcriptase | |
| BR0316771A (pt) | Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica | |
| BR0309581A (pt) | Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c | |
| EA200400585A1 (ru) | N-замещённые гидроксипиримидинон-карбоксамидные ингибиторы вич интегразы | |
| NO305478B1 (no) | Hydroksyetylaminosulfonamider som retrovirale proteasehemmere | |
| CY1110690T1 (el) | Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv | |
| ES2150933T3 (es) | Inhibidores de la proteasa vih utiles para el tratamiento del sida. | |
| MX9403380A (es) | Inhibidores de proteasa de vih utiles para el tratamiento de sida. | |
| ES2125251T3 (es) | Inhibidores de la proteasa del vih. | |
| DK0749421T3 (da) | Sulfonamidderivater som aspartylproteaseinhibitorer | |
| DE60036961D1 (de) | Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1-piperazinpentanamide als hiv-proteasehemmer | |
| UY26380A1 (es) | Inhibidores de fab i | |
| CY1106801T1 (el) | Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα | |
| SE0102315D0 (sv) | Compounds | |
| ES2051641B1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
| ES2101252T3 (es) | Inhibidores de la proteasa del hiv utiles para el tratamiento del sida. | |
| UY27577A1 (es) | Inhibidores de la integrasa del vih | |
| ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
| AR029544A1 (es) | Composiciones y metodos para tratar infecciones bacterianas | |
| DOP2002000449A (es) | Sal sodica de un inhibidor de integradasa del vih. | |
| CO4130200A1 (es) | Inhibidores de proteasa del hiv utiles en el tratamiento del sida | |
| GEAP202415903A (en) | Antimalarial agents | |
| PT1140113E (pt) | Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos | |
| ES2096874T3 (es) | Inhibidor de la proteasa de hiv util para el tratamiento del sida. |